Bioequivalence and Bioavailability Forum 02:25 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Regarding US FDA guidelines [Bioanalytics]

posted by sri - 2009-07-09 13:01  - Posting: # 3945
Views: 3,137

Dear all,
Please clarify me the below sentense which is present in 'Guidance for Industry Bioanalytical Method Validation'.

The calibration (standard) curve should cover the expected unknown sample concentration range in addition to a calibrator sample at lower limit of quantification.


Regards,
Sri

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,779 posts in 4,000 threads, 1,255 registered users;
online 14 (0 registered, 14 guests [including 12 identified bots]).

I have stopped reading Stephen King novels.
Now I just read C code instead.    Richard A. O'Keefe

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed